D

r. Deborah Dunsire is a biopharma lifer, rising to the upper ranks of Novartis before taking the helm of Millennium Pharmaceuticals right up until its $8.8 billion sale to Takeda. Now she’s back to lead a fledging upstart called XTuit Pharmaceuticals, a preclinical outfit crafting therapies for cancer and fibrotic disease.

Dunsire has also long been an advocate for gender diversity in biotech, and on this, International Women’s Day, we asked her how far the industry has come and how far it has to go.

This is a STAT Plus article and you can unlock it by subscribing to STAT Plus today. It's easy! Your first 30 days are free and if you don't enjoy your subscription you can cancel any time.
Already a subscriber? Log in here.

Leave a Comment

Please enter your name.
Please enter a comment.

Sign up for our Biotech newsletter — The Readout

Your daily guide to what’s new in biotech.